Skip to main content

Research Repository

Advanced Search

Mixed surfactant (altering chain length and head group) aggregates as an effective carrier for tuberculosis drug

Kumar, Arun; Rekha; Kansal, S. K.; Ibhadon, A. O.; Mehta, S. K.

Authors

Arun Kumar

Rekha

S. K. Kansal

Profile image of Alex Ibhadon

Dr Alex Ibhadon A.O.Ibhadon@hull.ac.uk
Reader, Catalysis and Reactor Engineering for Energy Generation and Chemical Synthesis

S. K. Mehta



Abstract

© 2018 Elsevier B.V. Surface properties and aggregation behavior of cationic-cationic and cationic-non-ionic mixed surfactant systems viz. Dodecylethyldimethylammonium bromide (DDAB) with a series of double chain cationic surfactants (DiDDAB, DMDTAB, and DODAB) and non-ionic surfactants (Brij 96, Tyloxapol and Tween 80) were analysed using surface tension and transmission electron microscopy (TEM). The effect of chain length of cationic surfactant and hydrophilic-lypophilic balance (HLB) prominently observed in critical aggregation (cac) value. The aqueous solubility of anti-tuberculosis drug: rifampicin (RIF) was comparatively studied by UV–vis spectroscopy in presence of formulated micelles and vesicles. RIF was significantly solubilised in aqueous medium using all the formulated aggregates. RIF is very unstable in basic medium (above pH-7) and in oxidizing media. Therefore, stability at pH-13 as well as in strong oxidising environment was monitored using UV–vis spectroscopy. To trace the locus of the drug encapsulation in the micelles/vesicles, fluorescence spectroscopy and TEM studies were carried out. Both the techniques stemmed in complimentary results and confirmed that, RIF is majorly populated at polar medium in cationic-cationic vesicles and favour to reside at hydrophobic medium of the nonionic-cationic micelles.

Citation

Kumar, A., Rekha, Kansal, S. K., Ibhadon, A. O., & Mehta, S. K. (2018). Mixed surfactant (altering chain length and head group) aggregates as an effective carrier for tuberculosis drug. Chemistry and Physics of Lipids, 215, 11-17. https://doi.org/10.1016/j.chemphyslip.2018.07.001

Journal Article Type Article
Acceptance Date Jul 1, 2018
Online Publication Date Jul 3, 2018
Publication Date 2018-09
Deposit Date May 3, 2022
Journal Chemistry and Physics of Lipids
Print ISSN 0009-3084
Publisher Elsevier
Peer Reviewed Peer Reviewed
Volume 215
Pages 11-17
DOI https://doi.org/10.1016/j.chemphyslip.2018.07.001
Keywords Anti-tuberculosis drug; Aqueous solubility; Drug stability; Mixed surfactant aggregates; Drug-surfactant interactions
Public URL https://hull-repository.worktribe.com/output/3589801